Thousands of WordPress sites running the Kali Forms plugin are exposed to attackers who can execute arbitrary code on web ...
ServiceNow says security researchers were behind activity linked to a newly patched authentication flaw, but the company ...
Enterprise security teams are auditing logs and rotating credentials this week after ServiceNow confirmed that attackers successfully queried sensitive customer instance data through an ...
POP-ROCKERS The Script have riled up their long-term fans ahead of releasing brand new music. The group have frustrated supporters by not addressing missing band-member Glen Power amid the release of ...
AI chatbots are turning into accidental snitches — and in some cases, they’re handing out real people’s phone numbers to total strangers. Privacy experts are ...
X has introduced strict daily technical limits for all unverified accounts on the platform. Free users are now capped at 50 original posts and 200 replies per day, down from a previous allowance of ...
A new study from CyberWell identified 307 posts that drew 30 million views across five major platforms over 13 months You can save this article by registering for free here. Or sign-in if you have an ...
Up to 2400 posts per day were previously allowed for X users. However, those who do not pay for Premium are now limited to only 50. The social media platform X is restricting free users: they have ...
Good news, OpenClaw fans — you can once again use your Claude AI subscription to power the hit, open source, autonomous AI agentic harness! But, there's a big catch with how it's being enacted. The ...
Drug gang members are escorting people into post offices to collect their social welfare payments — and then forcing them to immediately hand the cash over, the Sunday Independent has learned. There ...
X may have found a new way to nudge users toward its Premium subscriptions. As per a recent Help Center update, free X accounts are now limited to 50 posts and 200 replies per day, down significantly ...
CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...